The subject of the contract are medicinal products - anticancer agents described in detail in 64 parts

Various medicinal products

Acidum levofolinicum

Darbopoietin alpha

Erlotinib

Doxorubicinum liposomanum pegylatum

Vinorelbinum

Anagrelid

Imatinib

Fulvestrant

Themozolomidum

Pegasparagasum

Calcii folinas

Chlorambucilum

Peginterferon alpha-2a

Dexamethasoni phosphas

Netupitantum + Palonosetroni hydrochloridum

Anagrelid

Cladribinum

Cyclophosphamidum

Cyclophosphamidum

Fludarabini phosphas

Hydroxycarbamide

Filgrastim

Idarubicin

Iphosphamide

Mercaptopurinum

MESNA

Thioguanine

Topotecan

Carboplatin

cisplatinum

cytarabine

Docetaxel

Irinotecan

Doxorubicinum

Epirubicin

Etoposidum

Fluorouracilum

Gemcitabinum

Methotrexatum

Methotrexatum

Mythoxanthron

Paclitaxel

Pemetrexed

Bendamustine

Vinorelbin

Capecitabinum

Bleomycinum

Dacarbazinum

Topotecan

Methotrexatum

Bicalutamide

Doxorubicinum liposomanum nonpegylatum

Vincristinum

Denosumabum

Capecitabinum

Melphalanum

trastuzumab

Abiraterone acetate

Fluorouracilum

aprepitant

Busulfan

Gefitinibum

Oxaliplatin

BCG Vaccinum